Pure Global

Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006/KEYVIBE-006) - Trial PHRR230831-006071

Access comprehensive clinical trial information for PHRR230831-006071 through Pure Global AI's free database. This Phase 3 trial is sponsored by Merck Sharp & Dohme (I.A.) LLC and is currently Suspended. The study focuses on Carcinoma, Non-Small-Cell Lung.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Philippine Health Research Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
PHRR230831-006071
Phase 3
Suspended
Trial Details
Philippine Health Research Registry • PHRR230831-006071
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006/KEYVIBE-006)
Open-label Phase 3 Study of MK-7684A (Coformulation of Vibostolimab With Pembrolizumab) in Combination With Concurrent Chemoradiotherapy Followed by MK-7684A Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Unresectable, Locally Advanced, Stage III NSCLC

Study Focus

Interventional

Sponsor & Location

Merck Sharp & Dohme (I.A.) LLC

Australia;Brazil;Chile;China;Costa;Rica;Dominican;Republic;Germany;Greece;Guatemala;Israel;Italy;Jap

Timeline & Enrollment

Phase 3

Sep 22, 2023

N/A

ICD-10 Classifications

Carcinoma in situ: Bronchus and lung
Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung

Data Source

Philippine Health Research Registry

PHRR230831-006071

Non-Device Trial